Retinal displacement may be more severe and occurs more frequently in patients who undergo pars plana vitrectomy as opposed to pneumatic retinopexy for rhegmatogenous retinal detachment repair, ...
The inverted internal limiting membrane (ILM) flap technique results in significantly better vision in patients with macular hole-associated retinal detachment (MHRD) and highly myopic eyes when ...
The FDA has approved Eylea HD (aflibercept) 8 mg to treat patients with macular edema following retinal vein occlusion (RVO) with dosing of up to every 8 weeks after an initial monthly dosing period.
Retinal detachment happens when an injury causes the retina to peel away from the wall of the eye. It can happen quickly, or a small tear can continue to progress over time until the retina detaches. ...
Myopia, or nearsightedness, is a common eye condition. More than 40% of Americans can't see clearly at a distance because their eye is longer than normal. Usually myopia doesn't cause any problems ...
Please provide your email address to receive an email when new articles are posted on . Pars plana vitrectomy with internal limiting membrane peeling for macular hole closure is better than pars plana ...
First and only FDA-approved treatment for RVO indicated for up to every 8-week dosing after an initial monthly dosing period Monthly dosing ...
Lattice degeneration of the retina occurs when your retina gets thinner over time. About 10% of people experience this condition within their lifetime. It does not directly cause vision issues, but ...
The FDA approved Eylea HD for the treatment of macular edema following retinal vein occlusion, according to a press ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results